The latest call
FetchingElectromed, Inc. reported on November 10, 2026. We are fetching the call transcript; its summary follows once the transcript is in.
$24.32-2.6%Nov 13 close
Figures through September 30, 2026, from the 10-Q filed November 10, 2026
Just reported
From Electromed, Inc.'s results release of November 10, 2026; its quarterly report has since been filed.
Actual
$18.7M
+11% y/y
-3.8% q/q
Guided
—
No guide given
Actual
$0.32
+28% y/y
-18% q/q
Guided
—
No guide given
| Measure | 3 months toSep 30, 2026 | 3 months toSep 30, 2025 | Change |
|---|---|---|---|
| Total Revenue | $18.7M | $16.9M | +10.63% |
| Profit | $2.8M | $2.1M | +29.26% |
| Profit per share | $0.32 | $0.25 | +28.00% |
| Free Cash Flow | $208K | -$83K | +350.60% |
These are single quarters, not a trailing year — the figures elsewhere on this site cover twelve months and will be much larger. A seasonal business swings a long way between the two: ServiceNow earns $2.0B of free cash flow in its December quarter and $0.5B in its June one.
Compared against the same quarter a year earlier, not against an analyst forecast. A “beat” or “miss” needs a consensus estimate, which is licensed data we do not carry — and getting it wrong is worse than leaving it out.
Electromed, Inc. reported on November 10, 2026. We are fetching the call transcript; its summary follows once the transcript is in.
“We delivered our 16th consecutive quarter of year-over-year revenue and operating income growth, with double-digit revenue growth, a 30.7% increase in operating income and an 80.0% gross margin—demonstrating the strength of our direct-to-patient model and operating leverage. We also returned $4.3 million to shareholders through share repurchases while remaining debt-free. With a strong balance sheet and high-performing sales and fulfillment teams, Electromed is well positioned to bring SmartVest ® therapy to more patients who need to breathe easier,”
Quoted verbatim from the release, and shown only when the filing attributes it to a named person.
Releases land before the open or after the close, so the window runs from the close before the report day to the close of the session after it — the reaction is inside it either way.
Electromed, Inc. manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest® Airway Clearance System, to patients with compromised pulmonary function. It is headquartered in New Prague, Minnesota, and was founded in 1992. Further information about Electromed can be found at www.smartvest.com.
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from Electromed, Inc.’s Item 2.02 8-K filed November 10, 2026; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
Actual
$3.5M
+31% y/y
-8.8% q/q
Guided
—
No guide given
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.